adriamycin

Adriamycin的音标为["ædrɪəməʊɪn]，基本翻译为“阿霉素”，速记技巧为“阿地莫林”。

Adriamycin的英文词源：

Adriamycin是一个化学药物名称，源于其发明者Adria Research实验室。这个词由“Adria”和“mycin”两个部分组成。“Adria”来源于该实验室的所在地——Adria市，而“mycin”则来源于抗生素的分类，暗示着该药物具有类似抗生素的生物活性。

变化形式：

Adriamycin在英语中是名词形式，用于描述一种化疗药物。其复数形式为“adriamycins”，形容词形式为“adriamycin-like”。

相关单词：

1. anthracycline：蒽环类抗生素，是一类与Adriamycin相关的化疗药物。

2. cytotoxicity：细胞毒性，描述药物或毒素对细胞的杀伤力，与Adriamycin的化疗作用密切相关。

3. dosing：给药，指将药物按照规定剂量和方法加入到适当容器中，用于Adriamycin等化疗药物的注射。

4. cumulative dose：累积剂量，指在一段时间内接受的药物总量，过高累积剂量可能导致不良反应。

5. cardiotoxicity：心脏毒性，指Adriamycin等化疗药物对心脏的损伤，可能导致心律失常等严重后果。

6. resistance：耐药性，指细胞对药物的抵抗性，是化疗药物治疗过程中常见的问题。

7. therapeutic index：治疗指数，指药物在有效浓度和毒性浓度之间的范围，对于Adriamycin等化疗药物来说，寻找合适的剂量至关重要。

8. pharmacokinetics：药代动力学，研究药物在体内的吸收、分布、代谢和排泄过程的学科，对于理解Adriamycin等化疗药物的药效和副作用具有重要意义。

9. adjuvant therapy：辅助治疗，指在主要治疗手段之外的辅助治疗方法，如联合使用Adriamycin等化疗药物，以提高治疗效果。

10. alternative medicine：替代医学，一种非主流医学体系，有时会使用Adriamycin等化疗药物作为治疗手段，但需要注意其风险和副作用。

常用短语：

1. Adriamycin injection

2. Adriamycin chemotherapy

3. Adriamycin dosage

4. Adriamycin infusion

5. Adriamycin dosage schedule

6. Adriamycin side effects

7. Adriamycin resistance

双语例句：

1. Adriamycin is commonly used in chemotherapy to treat various types of cancer.

2. The dosage and schedule of Adriamycin should be carefully monitored to avoid excessive toxicity.

3. Some patients develop resistance to Adriamycin, making it necessary to explore alternative treatment options.

4. Side effects of Adriamycin can be severe and include nausea, vomiting, and hair loss.

5. Successful use of Adriamycin requires a thorough understanding of the patient"s condition and individual response to treatment.

6. Adriamycin is a powerful drug that can have a profound impact on the course of cancer treatment.

7. Despite its potential risks, Adriamycin remains a valuable tool in the fight against cancer.

英文小作文：

Adriamycin - The Powerful Chemotherapeutic Agent

Adriamycin, a powerful chemotherapy drug, has been used for decades to treat various types of cancer with varying degrees of success. It is commonly used in combination with other drugs to enhance its effectiveness and reduce the risk of resistance developing.

Adriamycin works by interfering with DNA replication, causing cells to die or stop dividing, thereby limiting the growth of tumors. However, it is not without risks and side effects can be severe, including nausea, vomiting, hair loss, and damage to the heart and kidneys. Therefore, it is essential to monitor the dosage and schedule carefully to avoid excessive toxicity and ensure the best possible outcomes for patients.

Despite its potential risks, Adriamycin remains a valuable tool in the fight against cancer. It has been instrumental in prolonging the lives of many patients and has even been used as a bridge to more advanced forms of treatment, such as bone marrow transplantation or immunotherapy.

Adriamycin has also opened up new avenues for research into the mechanisms of cancer cell death and has provided valuable insights into the role of DNA damage in tumorigenesis. As our understanding of this drug continues to evolve, we may see it being used in new and innovative ways to improve outcomes for patients with cancer.